Toll-like receptor patterns in epidermodysplasia verruciformis associated - squamous cell carcinomas.

IF 2.8 4区 医学 Q1 DERMATOLOGY
Cibele C A Pereira, Luis Alberto R Fróes, Lana Luiza C Silva, Maira G Saldanha, Naiura V Pereira, Walmar R P Oliveira, Mirian N Sotto
{"title":"Toll-like receptor patterns in epidermodysplasia verruciformis associated - squamous cell carcinomas.","authors":"Cibele C A Pereira, Luis Alberto R Fróes, Lana Luiza C Silva, Maira G Saldanha, Naiura V Pereira, Walmar R P Oliveira, Mirian N Sotto","doi":"10.1093/ced/llaf429","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Epidermodysplasia verruciformis (EV) is a rare genetic condition characterized by viral warts and an increased risk of squamous cell carcinoma (SCC), particularly associated with specific human papillomavirus (HPV) types, notably beta-HPV variants 5 and 8. Toll-like receptors (TLRs) are crucial for immune response regulation and may contribute to cancer development in EV.</p><p><strong>Objectives: </strong>This study aimed to assess the expression levels of TLRs 3, 4, 5, and 9 in SCC samples from EV patients versus those without EV (NEV) to understand their potential roles in EV-related carcinogenesis.</p><p><strong>Methods: </strong>We examined tumour samples from 18 patients with EV alongside samples from 90 NEV participants. Techniques included tissue microarray analysis and conventional histological evaluation, with immunohistochemistry performed to detect TLR expression. Controls were included to validate the specificity of the results, and statistical analyses employed the Kruskal-Wallis test with Dunn-Bonferroni post-hoc comparisons.</p><p><strong>Results: </strong>TLRs 3, 4, 5, and 9 were detected in both patient groups, with distinct expression patterns. TLR3 levels were higher in the normal skin of EV patients, while TLR9 was more prominent in tumours. In NEV patients, TLR3 and TLR4 expression varied with tumour stages; invasive SCC showed increased TLR5 and TLR9 levels. EV samples showed significantly higher TLR4 and TLR9 expression relative to NEV samples.</p><p><strong>Conclusions: </strong>The differing TLR expression patterns indicate diverse immune mechanisms involved in EV-related carcinogenesis, suggesting that TLRs could be potential therapeutic targets, meriting further investigation into their roles in tumour growth regulation.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ced/llaf429","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Epidermodysplasia verruciformis (EV) is a rare genetic condition characterized by viral warts and an increased risk of squamous cell carcinoma (SCC), particularly associated with specific human papillomavirus (HPV) types, notably beta-HPV variants 5 and 8. Toll-like receptors (TLRs) are crucial for immune response regulation and may contribute to cancer development in EV.

Objectives: This study aimed to assess the expression levels of TLRs 3, 4, 5, and 9 in SCC samples from EV patients versus those without EV (NEV) to understand their potential roles in EV-related carcinogenesis.

Methods: We examined tumour samples from 18 patients with EV alongside samples from 90 NEV participants. Techniques included tissue microarray analysis and conventional histological evaluation, with immunohistochemistry performed to detect TLR expression. Controls were included to validate the specificity of the results, and statistical analyses employed the Kruskal-Wallis test with Dunn-Bonferroni post-hoc comparisons.

Results: TLRs 3, 4, 5, and 9 were detected in both patient groups, with distinct expression patterns. TLR3 levels were higher in the normal skin of EV patients, while TLR9 was more prominent in tumours. In NEV patients, TLR3 and TLR4 expression varied with tumour stages; invasive SCC showed increased TLR5 and TLR9 levels. EV samples showed significantly higher TLR4 and TLR9 expression relative to NEV samples.

Conclusions: The differing TLR expression patterns indicate diverse immune mechanisms involved in EV-related carcinogenesis, suggesting that TLRs could be potential therapeutic targets, meriting further investigation into their roles in tumour growth regulation.

疣状表皮发育不良相关鳞状细胞癌的toll样受体模式。
背景:疣状表皮发育不良(EV)是一种罕见的遗传病,其特征是病毒性疣和鳞状细胞癌(SCC)的风险增加,特别是与特定的人乳头瘤病毒(HPV)类型相关,特别是β -HPV变体5和8。toll样受体(TLRs)在免疫反应调节中起着至关重要的作用,可能与EV的癌症发展有关。目的:本研究旨在评估TLRs 3、4、5和9在EV患者和无EV (NEV)患者的SCC样本中的表达水平,以了解它们在EV相关癌变中的潜在作用。方法:我们检查了来自18例EV患者和90例NEV参与者的肿瘤样本。技术包括组织微阵列分析和常规组织学评估,免疫组织化学检测TLR表达。纳入对照以验证结果的特异性,统计分析采用Kruskal-Wallis检验和Dunn-Bonferroni事后比较。结果:两组患者均检测到TLRs 3、4、5、9,表达模式不同。TLR3水平在EV患者的正常皮肤中较高,而TLR9在肿瘤中更为突出。在NEV患者中,TLR3和TLR4的表达随肿瘤分期而变化;侵袭性SCC表现为TLR5、TLR9水平升高。与新能源汽车样品相比,电动汽车样品的TLR4和TLR9的表达明显更高。结论:不同的TLR表达模式提示不同的免疫机制参与ev相关的癌变,提示TLR可能是潜在的治疗靶点,值得进一步研究其在肿瘤生长调节中的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.20
自引率
2.40%
发文量
389
审稿时长
3-8 weeks
期刊介绍: Clinical and Experimental Dermatology (CED) is a unique provider of relevant and educational material for practising clinicians and dermatological researchers. We support continuing professional development (CPD) of dermatology specialists to advance the understanding, management and treatment of skin disease in order to improve patient outcomes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信